We're all familiar with two dimensional design drawings — not to mention the questions that usually accompany them because they can provide only so much information before becoming hopelessly ...

CardioDx Also Separately Raises $20 Million in New Financing to Support the Company's Commercial Growth and Operations CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular ...

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that Palmetto GBA, a national contractor that administers Medicare benefits, has established coverage for ...

Blood-Based Test Has Potential to Improve Quality of Care and Lower Costs of Evaluation of Obstructive Coronary Artery Disease REDWOOD CITY, Calif. – CardioDx, Inc., a molecular diagnostics company ...

Researchers have completed an observational validation study of a new genomic test for obstructive coronary artery disease for patients presenting with stable chest pain, but will release results ...

Quest Diagnostics Inc.DGX recently entered into a national specimen-draw agreement with CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics. Per the agreement, both ...

Working hard on a new design and want to share it with your co-workers? With an easy-to-use app called AutoCAD 360, you can view, edit, and share your AutoCAD drawings anytime, anywhere. This handy ...

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced online publication of a study in the The paper, titled “A Gender Specific Blood-Based Gene Expression ...

Coverage of Blood-Based Test Has Potential to Improve Quality of Care and Lower Costs of Diagnosis of Obstructive Coronary Artery Disease Beyond Traditional Methods PALO ALTO, Calif. – CardioDx, Inc., ...